807 related articles for article (PubMed ID: 30847938)
1. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
Jia L; Sun P; Gao H; Shen J; Gao Y; Meng C; Fu S; Yao H; Zhang G
J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
3. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
5. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
6. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
7. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
8. Mushroom Inonotus sanghuang alleviates experimental pulmonary fibrosis: Implications for therapy of pulmonary fibrosis.
Su X; Liu K; Xie Y; Zhang M; Wu X; Zhang Y; Wang J
Biomed Pharmacother; 2021 Jan; 133():110919. PubMed ID: 33202282
[TBL] [Abstract][Full Text] [Related]
9. Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways.
Hao W; Yu TT; Zuo DZ; Hu HZ; Zhou PP
Exp Lung Res; 2023 Nov; 49(1):205-219. PubMed ID: 38044666
[No Abstract] [Full Text] [Related]
10. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
11. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
[TBL] [Abstract][Full Text] [Related]
12. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Jin M; Wu Y; Wang L; Zang B; Tan L
Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
[TBL] [Abstract][Full Text] [Related]
14. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
[TBL] [Abstract][Full Text] [Related]
15. Danggui Buxue Tang ameliorates bleomycin-induced pulmonary fibrosis in rats through inhibiting transforming growth factor-β1/Smad3/ plasminogen activator inhibitor-1 signaling pathway.
Wang J; Fang C; Wang S; Fang F; Chu X; Liu N; Lu C; Wang S; Li W
J Tradit Chin Med; 2020 Apr; 40(2):236-244. PubMed ID: 32242389
[TBL] [Abstract][Full Text] [Related]
16. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
17. β-carboline alkaloids attenuate bleomycin induced pulmonary fibrosis in mice through inhibiting NF-kb/p65 phosphorylation and epithelial-mesenchymal transition.
Cui Y; Jiang L; Yu R; Shao Y; Mei L; Tao Y
J Ethnopharmacol; 2019 Oct; 243():112096. PubMed ID: 31323300
[TBL] [Abstract][Full Text] [Related]
18. [Aqueous extract of Epimedium sagittatum mitigates pulmonary fibrosis in mice].
Wang R; Hou FY; Zeng MN; Zhang BB; Zhang QQ; Xie SS; Feng WS; Zheng XK
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5612-5622. PubMed ID: 38114154
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling.
Zhang YQ; Liu YJ; Mao YF; Dong WW; Zhu XY; Jiang L
Clin Nutr; 2015 Aug; 34(4):752-60. PubMed ID: 25234611
[TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
